|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Epstein-Barr Virus (VCA) IgA ELISA | Anti-Ustekinumab (Stelara®) ELISA | Complement System MBL Pathway ELISA Assay | Estradiol ELISA | Tenascin-C High Molecular Weight Variants ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB79862 | TM09036 | COMPL MP320 RUO | IB79103 | 27751 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay (ELISA) for the determination of specific IgA antibodies against EBV VCA in serum and plasma. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | The Wieslab® COMPL MP320 kit is an enzyme immunoassay for the determination of MBL complement pathway in human serum. For research use only, not for use in diagnostic procedures. | Competitive enzyme immunoassay for the quantitative measurement of Estradiol in serum or plasma (EDTA, lithium heparin, or citrate plasma). 510(k) Exempt, can be used for in-vitro diagnostics. | Solid phase sandwich ELISA for the determination of Human Tenascin-C containing high molecular weight variants (Human Tenascin-C HMWV) in serum, plasma (heparin), or cell culture media. For research use only, not for use in diagnostic procedures. |
| Detection Target | Thyroid Stimulating Hormone | sAPP Total | Human secreted Alpha Klotho (a-Klotho) | Progesterone | CA 242 |
| Sample Type | Serum, Blood Plasma | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum, EDTA-plasma, and cerebrospinal fluid (CSF). | Serum, Blood Plasma | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | A cut-off control is used for the interpretation of results. | Anti-Ustekinumab (Stelara®) | Inquire | 0 / 25 - 2000 pg/mL | 0.38 to 24 ng/mL |
| Sensitivity | Inquire | 0.06 ng/mL | 9.87 pg/mL | 0.045 ng/mL | Inquire |
| Assay Time | 1 hr, 45 mins (incubation) | 2 hour, 30 min. total incubation time. | 2 hrs (incubation) | 2 hours total incubation time. | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |